FHIR © HL7.org  |  Server Home  |  FHIR Server FHIR Server 3.7.4-SNAPSHOT  |  FHIR Version n/a  User: [n/a]

410867006: Product containing precisely clemastine fumarate 335 microgram and paracetamol 500 milligram and phenylpropanolamine 30 milligram/1 each conventional release oral tablet (clinical drug)

Status: current, Sufficiently defined by necessary conditions definition status (core metadata concept). Date: 31-Jul 2018. Module: SNOMED CT core

Descriptions:

Id Description Lang Type Status Case? Module
3699530010 Product containing precisely clemastine fumarate 335 microgram and paracetamol 500 milligram and phenylpropanolamine 30 milligram/1 each conventional release oral tablet (clinical drug) en Fully specified name Active Entire term case insensitive (core metadata concept) SNOMED CT core
3699532019 Clemastine fumarate 335 microgram and paracetamol 500 mg and phenylpropanolamine 30 mg oral tablet en Synonym (core metadata concept) Active Entire term case insensitive (core metadata concept) SNOMED CT core
3699533012 Acetaminophen 500 mg and clemastine fumarate 335 microgram and phenylpropanolamine 30 mg oral tablet en Synonym (core metadata concept) Active Entire term case insensitive (core metadata concept) SNOMED CT core
2466318015 Clemastine fumarate 0.335mg/phenylpropanolamine hydrochloride 30mg/acetaminophen 500mg tablet (product) en Fully specified name Active Only initial character case insensitive (core metadata concept) SNOMED CT core
2472517010 Clemastine fumarate 0.335mg/phenylpropanolamine hydrochloride 30mg/acetaminophen 500mg tablet en Synonym (core metadata concept) Active Only initial character case insensitive (core metadata concept) SNOMED CT core
2820220019 Clemastine fumarate + phenylpropanolamine hydrochloride + acetaminophen 0.335mg/30mg/500mg tablet en Synonym (core metadata concept) Active Only initial character case insensitive (core metadata concept) SNOMED CT core
2820221015 Clemastine fumarate + phenylpropanolamine hydrochloride + paracetamol 0.335mg/30mg/500mg tablet en Synonym (core metadata concept) Active Only initial character case insensitive (core metadata concept) SNOMED CT core
2820222010 Clemastine fumarate + phenylpropanolamine hydrochloride + acetaminophen 0.335mg/30mg/500mg tablet (product) en Fully specified name Active Only initial character case insensitive (core metadata concept) SNOMED CT core
3486789012 Product containing clemastine fumarate 0.335 mg and phenylpropanolamine hydrochloride 30 mg and paracetamol 500 mg/1 each oral tablet (clinical drug) en Fully specified name Active Entire term case insensitive (core metadata concept) SNOMED CT core
3495142013 Product containing clemastine fumarate 0.335 mg and phenylpropanolamine hydrochloride 30 mg and acetaminophen 500 mg/1 each oral tablet en Synonym (core metadata concept) Active Entire term case insensitive (core metadata concept) SNOMED CT core
3495144014 Product containing clemastine fumarate 0.335 mg and phenylpropanolamine hydrochloride 30 mg and paracetamol 500 mg/1 each oral tablet en Synonym (core metadata concept) Active Entire term case insensitive (core metadata concept) SNOMED CT core
3501957018 Clemastine fumarate 0.335 mg and phenylpropanolamine hydrochloride 30 mg and paracetamol 500 mg oral tablet en Synonym (core metadata concept) Active Entire term case insensitive (core metadata concept) SNOMED CT core
3501958011 Clemastine fumarate 0.335 mg and phenylpropanolamine hydrochloride 30 mg and acetaminophen 500 mg oral tablet en Synonym (core metadata concept) Active Entire term case insensitive (core metadata concept) SNOMED CT core
3570002018 Product containing only clemastine fumarate 0.335 mg and phenylpropanolamine hydrochloride 30 mg and paracetamol 500 mg/1 each oral tablet (clinical drug) en Fully specified name Active Entire term case insensitive (core metadata concept) SNOMED CT core
3570003011 Product containing only clemastine fumarate 0.335 mg and phenylpropanolamine hydrochloride 30 mg and paracetamol 500 mg/1 each oral tablet en Synonym (core metadata concept) Active Entire term case insensitive (core metadata concept) SNOMED CT core
3570004017 Product containing only clemastine fumarate 0.335 mg and phenylpropanolamine hydrochloride 30 mg and acetaminophen 500 mg/1 each oral tablet en Synonym (core metadata concept) Active Entire term case insensitive (core metadata concept) SNOMED CT core
3699530010 Product containing precisely clemastine fumarate 335 microgram and paracetamol 500 milligram and phenylpropanolamine 30 milligram/1 each conventional release oral tablet (clinical drug) en Fully specified name Active Entire term case insensitive (core metadata concept) SNOMED CT core
3699531014 Product containing precisely clemastine fumarate 335 microgram and paracetamol 500 milligram and phenylpropanolamine 30 milligram/1 each conventional release oral tablet en Synonym (core metadata concept) Active Entire term case insensitive (core metadata concept) SNOMED CT core
3699532019 Clemastine fumarate 335 microgram and paracetamol 500 mg and phenylpropanolamine 30 mg oral tablet en Synonym (core metadata concept) Active Entire term case insensitive (core metadata concept) SNOMED CT core
3699533012 Acetaminophen 500 mg and clemastine fumarate 335 microgram and phenylpropanolamine 30 mg oral tablet en Synonym (core metadata concept) Active Entire term case insensitive (core metadata concept) SNOMED CT core

0 descendants.

Expanded Value Set

Outbound Relationships Type Target Active Characteristic Refinability Group Values
Clemastine fumarate 0.335mg/phenylpropanolamine hydrochloride 30mg/acetaminophen 500mg tablet Is a Product containing clemastine fumarate and paracetamol and phenylpropanolamine false Inferred relationship Existential restriction modifier (core metadata concept)
Clemastine fumarate 0.335mg/phenylpropanolamine hydrochloride 30mg/acetaminophen 500mg tablet The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. Paracetamol false Inferred relationship Existential restriction modifier (core metadata concept)
Clemastine fumarate 0.335mg/phenylpropanolamine hydrochloride 30mg/acetaminophen 500mg tablet The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. Phenylpropanolamine false Inferred relationship Existential restriction modifier (core metadata concept)
Clemastine fumarate 0.335mg/phenylpropanolamine hydrochloride 30mg/acetaminophen 500mg tablet The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. Clemastine fumarate false Inferred relationship Existential restriction modifier (core metadata concept)
Clemastine fumarate 0.335mg/phenylpropanolamine hydrochloride 30mg/acetaminophen 500mg tablet The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. Ethanolamine false Inferred relationship Existential restriction modifier (core metadata concept)
Clemastine fumarate 0.335mg/phenylpropanolamine hydrochloride 30mg/acetaminophen 500mg tablet Has manufactured dose form A solid single-dose preparation obtained by compressing uniform volumes of particulate solids or by extrusion or moulding. Tablets may be single layer tablets resulting from a single compression of particles and or multilayer tablets consisting of concentric or parallel layers obtained by successive compressions of particles of different composition. false Inferred relationship Existential restriction modifier (core metadata concept)
Clemastine fumarate 0.335mg/phenylpropanolamine hydrochloride 30mg/acetaminophen 500mg tablet The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. agent cardiovasculaire false Inferred relationship Existential restriction modifier (core metadata concept)
Clemastine fumarate 0.335mg/phenylpropanolamine hydrochloride 30mg/acetaminophen 500mg tablet Has manufactured dose form Conventional release oral tablet (dose form) true Inferred relationship Existential restriction modifier (core metadata concept)
Clemastine fumarate 0.335mg/phenylpropanolamine hydrochloride 30mg/acetaminophen 500mg tablet Is a Product containing paracetamol in oral dose form (medicinal product form) false Inferred relationship Existential restriction modifier (core metadata concept)
Clemastine fumarate 0.335mg/phenylpropanolamine hydrochloride 30mg/acetaminophen 500mg tablet The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. Phenylpropanolamine false Inferred relationship Existential restriction modifier (core metadata concept) 1
Clemastine fumarate 0.335mg/phenylpropanolamine hydrochloride 30mg/acetaminophen 500mg tablet Has basis of strength substance (attribute) Phenylpropanolamine true Inferred relationship Existential restriction modifier (core metadata concept) 1
Clemastine fumarate 0.335mg/phenylpropanolamine hydrochloride 30mg/acetaminophen 500mg tablet Has presentation strength numerator value 30 false Inferred relationship Existential restriction modifier (core metadata concept) 1
Clemastine fumarate 0.335mg/phenylpropanolamine hydrochloride 30mg/acetaminophen 500mg tablet Has presentation strength numerator unit (attribute) mg true Inferred relationship Existential restriction modifier (core metadata concept) 1
Clemastine fumarate 0.335mg/phenylpropanolamine hydrochloride 30mg/acetaminophen 500mg tablet Has presentation strength denominator value un false Inferred relationship Existential restriction modifier (core metadata concept) 1
Clemastine fumarate 0.335mg/phenylpropanolamine hydrochloride 30mg/acetaminophen 500mg tablet Has presentation strength denominator unit (attribute) Tablet (unit of presentation) true Inferred relationship Existential restriction modifier (core metadata concept) 1
Clemastine fumarate 0.335mg/phenylpropanolamine hydrochloride 30mg/acetaminophen 500mg tablet The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. Paracetamol false Inferred relationship Existential restriction modifier (core metadata concept) 2
Clemastine fumarate 0.335mg/phenylpropanolamine hydrochloride 30mg/acetaminophen 500mg tablet Has basis of strength substance (attribute) Paracetamol true Inferred relationship Existential restriction modifier (core metadata concept) 2
Clemastine fumarate 0.335mg/phenylpropanolamine hydrochloride 30mg/acetaminophen 500mg tablet Has presentation strength numerator value 500 false Inferred relationship Existential restriction modifier (core metadata concept) 2
Clemastine fumarate 0.335mg/phenylpropanolamine hydrochloride 30mg/acetaminophen 500mg tablet Has presentation strength numerator unit (attribute) mg true Inferred relationship Existential restriction modifier (core metadata concept) 2
Clemastine fumarate 0.335mg/phenylpropanolamine hydrochloride 30mg/acetaminophen 500mg tablet Has presentation strength denominator value un false Inferred relationship Existential restriction modifier (core metadata concept) 2
Clemastine fumarate 0.335mg/phenylpropanolamine hydrochloride 30mg/acetaminophen 500mg tablet Has presentation strength denominator unit (attribute) Tablet (unit of presentation) true Inferred relationship Existential restriction modifier (core metadata concept) 2
Clemastine fumarate 0.335mg/phenylpropanolamine hydrochloride 30mg/acetaminophen 500mg tablet The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. Clemastine fumarate false Inferred relationship Existential restriction modifier (core metadata concept) 3
Clemastine fumarate 0.335mg/phenylpropanolamine hydrochloride 30mg/acetaminophen 500mg tablet Has basis of strength substance (attribute) Clemastine fumarate true Inferred relationship Existential restriction modifier (core metadata concept) 3
Clemastine fumarate 0.335mg/phenylpropanolamine hydrochloride 30mg/acetaminophen 500mg tablet Has presentation strength numerator value 0.335 false Inferred relationship Existential restriction modifier (core metadata concept) 3
Clemastine fumarate 0.335mg/phenylpropanolamine hydrochloride 30mg/acetaminophen 500mg tablet Has presentation strength numerator unit (attribute) mg false Inferred relationship Existential restriction modifier (core metadata concept) 3
Clemastine fumarate 0.335mg/phenylpropanolamine hydrochloride 30mg/acetaminophen 500mg tablet Has presentation strength denominator value un false Inferred relationship Existential restriction modifier (core metadata concept) 3
Clemastine fumarate 0.335mg/phenylpropanolamine hydrochloride 30mg/acetaminophen 500mg tablet Has presentation strength denominator unit (attribute) Tablet (unit of presentation) true Inferred relationship Existential restriction modifier (core metadata concept) 3
Clemastine fumarate 0.335mg/phenylpropanolamine hydrochloride 30mg/acetaminophen 500mg tablet Has basis of strength substance (attribute) Paracetamol false Inferred relationship Existential restriction modifier (core metadata concept) 3
Clemastine fumarate 0.335mg/phenylpropanolamine hydrochloride 30mg/acetaminophen 500mg tablet Has presentation strength numerator value 500 false Inferred relationship Existential restriction modifier (core metadata concept) 3
Clemastine fumarate 0.335mg/phenylpropanolamine hydrochloride 30mg/acetaminophen 500mg tablet Has basis of strength substance (attribute) Phenylpropanolamine false Inferred relationship Existential restriction modifier (core metadata concept) 2
Clemastine fumarate 0.335mg/phenylpropanolamine hydrochloride 30mg/acetaminophen 500mg tablet Has presentation strength numerator value 30 false Inferred relationship Existential restriction modifier (core metadata concept) 2
Clemastine fumarate 0.335mg/phenylpropanolamine hydrochloride 30mg/acetaminophen 500mg tablet Has basis of strength substance (attribute) Clemastine fumarate false Inferred relationship Existential restriction modifier (core metadata concept) 1
Clemastine fumarate 0.335mg/phenylpropanolamine hydrochloride 30mg/acetaminophen 500mg tablet Has precise active ingredient Phenylpropanolamine false Inferred relationship Existential restriction modifier (core metadata concept) 2
Clemastine fumarate 0.335mg/phenylpropanolamine hydrochloride 30mg/acetaminophen 500mg tablet Has unit of presentation Tablet (unit of presentation) true Inferred relationship Existential restriction modifier (core metadata concept)
Clemastine fumarate 0.335mg/phenylpropanolamine hydrochloride 30mg/acetaminophen 500mg tablet Has precise active ingredient Paracetamol false Inferred relationship Existential restriction modifier (core metadata concept) 3
Clemastine fumarate 0.335mg/phenylpropanolamine hydrochloride 30mg/acetaminophen 500mg tablet Has precise active ingredient Clemastine fumarate false Inferred relationship Existential restriction modifier (core metadata concept) 1
Clemastine fumarate 0.335mg/phenylpropanolamine hydrochloride 30mg/acetaminophen 500mg tablet Is a Product containing clemastine and paracetamol and phenylpropanolamine in oral dose form (medicinal product form) false Inferred relationship Existential restriction modifier (core metadata concept)
Clemastine fumarate 0.335mg/phenylpropanolamine hydrochloride 30mg/acetaminophen 500mg tablet Count of base of active ingredient trois false Inferred relationship Existential restriction modifier (core metadata concept)
Clemastine fumarate 0.335mg/phenylpropanolamine hydrochloride 30mg/acetaminophen 500mg tablet Has presentation strength numerator unit (attribute) mcg false Inferred relationship Existential restriction modifier (core metadata concept) 1
Clemastine fumarate 0.335mg/phenylpropanolamine hydrochloride 30mg/acetaminophen 500mg tablet Has presentation strength numerator value 335 false Inferred relationship Existential restriction modifier (core metadata concept) 1
Clemastine fumarate 0.335mg/phenylpropanolamine hydrochloride 30mg/acetaminophen 500mg tablet Is a Clemastine and paracetamol and phenylpropanolamine only product in oral dose form true Inferred relationship Existential restriction modifier (core metadata concept)
Clemastine fumarate 0.335mg/phenylpropanolamine hydrochloride 30mg/acetaminophen 500mg tablet Has precise active ingredient Clemastine fumarate true Inferred relationship Existential restriction modifier (core metadata concept) 3
Clemastine fumarate 0.335mg/phenylpropanolamine hydrochloride 30mg/acetaminophen 500mg tablet Has precise active ingredient Paracetamol true Inferred relationship Existential restriction modifier (core metadata concept) 2
Clemastine fumarate 0.335mg/phenylpropanolamine hydrochloride 30mg/acetaminophen 500mg tablet Has presentation strength numerator unit (attribute) mcg true Inferred relationship Existential restriction modifier (core metadata concept) 3
Clemastine fumarate 0.335mg/phenylpropanolamine hydrochloride 30mg/acetaminophen 500mg tablet Has precise active ingredient Phenylpropanolamine true Inferred relationship Existential restriction modifier (core metadata concept) 1
Inbound Relationships Type Active Source Characteristic Refinability Group

This concept is not in any reference sets

Back to Start